137 related articles for article (PubMed ID: 10884881)
1. Expression of p19INK4d, CDK4, CDK6 in glioblastoma multiforme.
Lam PY; Di Tomaso E; Ng HK; Pang JC; Roussel MF; Hjelm NM
Br J Neurosurg; 2000 Feb; 14(1):28-32. PubMed ID: 10884881
[TBL] [Abstract][Full Text] [Related]
2. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
Easton J; Wei T; Lahti JM; Kidd VJ
Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a.
Russo AA; Tong L; Lee JO; Jeffrey PD; Pavletich NP
Nature; 1998 Sep; 395(6699):237-43. PubMed ID: 9751050
[TBL] [Abstract][Full Text] [Related]
4. Lack of mutation in the cyclin-dependent kinase inhibitor, p19INK4d, in tumor-derived cell lines and primary tumors.
Zariwala M; Xiong Y
Oncogene; 1996 Nov; 13(9):2033-8. PubMed ID: 8934552
[TBL] [Abstract][Full Text] [Related]
5. Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.
Guan KL; Jenkins CW; Li Y; O'Keefe CL; Noh S; Wu X; Zariwala M; Matera AG; Xiong Y
Mol Biol Cell; 1996 Jan; 7(1):57-70. PubMed ID: 8741839
[TBL] [Abstract][Full Text] [Related]
6. Lack of p19INK4d in human testicular germ-cell tumours contrasts with high expression during normal spermatogenesis.
Bartkova J; Thullberg M; Rajpert-De Meyts E; Skakkebaek NE; Bartek J
Oncogene; 2000 Aug; 19(36):4146-50. PubMed ID: 10962575
[TBL] [Abstract][Full Text] [Related]
7. Frequent deregulation of p16 and the p16/G1 cell cycle-regulatory pathway in neuroblastoma.
Diccianni MB; Omura-Minamisawa M; Batova A; Le T; Bridgeman L; Yu AL
Int J Cancer; 1999 Jan; 80(1):145-54. PubMed ID: 9935245
[TBL] [Abstract][Full Text] [Related]
8. Expression and regulation of G1 cell-cycle inhibitors (p16INK4A, p15INK4B, p18INK4C, p19INK4D) in human acute myeloid leukemia and normal myeloid cells.
Schwaller J; Pabst T; Koeffler HP; Niklaus G; Loetscher P; Fey MF; Tobler A
Leukemia; 1997 Jan; 11(1):54-63. PubMed ID: 9001419
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus-mediated overexpression of p15INK4B inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16INK4A.
Fuxe J; Akusjärvi G; Goike HM; Roos G; Collins VP; Pettersson RF
Cell Growth Differ; 2000 Jul; 11(7):373-84. PubMed ID: 10939591
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure of the complex of the cyclin D-dependent kinase Cdk6 bound to the cell-cycle inhibitor p19INK4d.
Brotherton DH; Dhanaraj V; Wick S; Brizuela L; Domaille PJ; Volyanik E; Xu X; Parisini E; Smith BO; Archer SJ; Serrano M; Brenner SL; Blundell TL; Laue ED
Nature; 1998 Sep; 395(6699):244-50. PubMed ID: 9751051
[TBL] [Abstract][Full Text] [Related]
11. Induction of p18INK4c and its predominant association with CDK4 and CDK6 during myogenic differentiation.
Franklin DS; Xiong Y
Mol Biol Cell; 1996 Oct; 7(10):1587-99. PubMed ID: 8898364
[TBL] [Abstract][Full Text] [Related]
12. CDK4, CDK6, cyclin D1, p16(INK4a) and EGFR expression in glioblastoma with a primitive neuronal component.
Xu G; Li JY
J Neurooncol; 2018 Feb; 136(3):445-452. PubMed ID: 29150788
[TBL] [Abstract][Full Text] [Related]
13. p16INK4a and p19INK4d mRNA expression in neuroglial tumours: correlation with Ki67 proliferation index.
Bouvier-Labit C; Civatte M; Bartoli C; Renaud W; Pellissier JF; Figarella-Branger D
Neuropathol Appl Neurobiol; 1999 Oct; 25(5):408-16. PubMed ID: 10564531
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha-induced G1 phase arrest through up-regulated expression of CDK inhibitors, p19Ink4D and p21Cip1 in mouse macrophages.
Matsuoka M; Tani K; Asano S
Oncogene; 1998 Apr; 16(16):2075-86. PubMed ID: 9572488
[TBL] [Abstract][Full Text] [Related]
15. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.
Shapiro GI; Park JE; Edwards CD; Mao L; Merlo A; Sidransky D; Ewen ME; Rollins BJ
Cancer Res; 1995 Dec; 55(24):6200-9. PubMed ID: 8521414
[TBL] [Abstract][Full Text] [Related]
16. Structure of human cyclin-dependent kinase inhibitor p19INK4d: comparison to known ankyrin-repeat-containing structures and implications for the dysfunction of tumor suppressor p16INK4a.
Baumgartner R; Fernandez-Catalan C; Winoto A; Huber R; Engh RA; Holak TA
Structure; 1998 Oct; 6(10):1279-90. PubMed ID: 9782052
[TBL] [Abstract][Full Text] [Related]
17. Expression of INK4 inhibitors of cyclin D-dependent kinases during mouse brain development.
Zindy F; Soares H; Herzog KH; Morgan J; Sherr CJ; Roussel MF
Cell Growth Differ; 1997 Nov; 8(11):1139-50. PubMed ID: 9372237
[TBL] [Abstract][Full Text] [Related]
18. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells.
Said TK; Medina D
Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257
[TBL] [Abstract][Full Text] [Related]
19. Human glioblastomas with no alterations of the CDKN2A (p16INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene.
Ichimura K; Schmidt EE; Goike HM; Collins VP
Oncogene; 1996 Sep; 13(5):1065-72. PubMed ID: 8806696
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of cyclin D-CDK4/CDK6 activity is associated with an E2F-mediated induction of cyclin kinase inhibitor activity.
Khleif SN; DeGregori J; Yee CL; Otterson GA; Kaye FJ; Nevins JR; Howley PM
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4350-4. PubMed ID: 8633069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
